Company intelligence / Profile preview

Shanghai Grand Financial Investment

Ownership: Private
Development stage: Other

Overview

Shanghai Grand Financial Investment is an investment management company based in China. It serves as a holding and financial management entity, notably for China Grand Pharmaceutical Group Limited ("Grand Pharma"), which operates in the pharmaceutical, nuclear medicine, medical device, and biotechnology sectors. The company itself does not conduct R&D or clinical trials but plays a key role in corporate structure and financing within the broader healthcare group.

Industry: Investors

Beyond the preview

Go deeper on Shanghai Grand Financial Investment.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Grand Financial Investment.

Explore the full profile